Research programme: insulin secretagogues - Novo Nordisk

Drug Profile

Research programme: insulin secretagogues - Novo Nordisk

Alternative Names: NNC 770020; NNC 770074

Latest Information Update: 13 Oct 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Novo Nordisk
  • Class Imidazolines; Small molecules
  • Mechanism of Action Alpha 2 adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Diabetes mellitus

Most Recent Events

  • 26 Sep 2008 Discontinued - Preclinical for Diabetes mellitus in Denmark (unspecified route)
  • 09 Jun 2003 A preclinical study has been added to the Diabetes mellitus pharmacodynamics section
  • 16 Sep 2002 Preclinical trials in Diabetes mellitus in Denmark (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top